- Home
- ICCC vs MGLD Comparison
ICCC vs MGLD Comparison
Compare ICCC & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- MGLD
- Stock Information
- Founded
- ICCC 1982
- MGLD 1996
- Country
- ICCC United States
- MGLD United States
- Employees
- ICCC N/A
- MGLD N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- ICCC Health Care
- MGLD Finance
- Exchange
- ICCC Nasdaq
- MGLD Nasdaq
- Market Cap
- ICCC 55.5M
- MGLD 44.8M
- IPO Year
- ICCC 1987
- MGLD N/A
- Fundamental
- Price
- ICCC $6.19
- MGLD $1.03
- Analyst Decision
- ICCC
- MGLD
- Analyst Count
- ICCC 0
- MGLD 0
- Target Price
- ICCC N/A
- MGLD N/A
- AVG Volume (30 Days)
- ICCC 18.9K
- MGLD 9.4K
- Earning Date
- ICCC 11-13-2025
- MGLD 11-07-2025
- Dividend Yield
- ICCC N/A
- MGLD N/A
- EPS Growth
- ICCC N/A
- MGLD N/A
- EPS
- ICCC 0.20
- MGLD N/A
- Revenue
- ICCC $28,274,756.00
- MGLD $30,154,000.00
- Revenue This Year
- ICCC N/A
- MGLD N/A
- Revenue Next Year
- ICCC N/A
- MGLD N/A
- P/E Ratio
- ICCC $31.45
- MGLD N/A
- Revenue Growth
- ICCC 21.75
- MGLD N/A
- 52 Week Low
- ICCC $3.38
- MGLD $0.64
- 52 Week High
- ICCC $7.60
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- ICCC 50.47
- MGLD 50.10
- Support Level
- ICCC $6.07
- MGLD $0.99
- Resistance Level
- ICCC $6.31
- MGLD $1.06
- Average True Range (ATR)
- ICCC 0.28
- MGLD 0.03
- MACD
- ICCC 0.01
- MGLD -0.01
- Stochastic Oscillator
- ICCC 44.19
- MGLD 39.13
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.